Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • About Us
  • Fund
  • Support
  • Return
  • Our DNA
  • News
  • Join Our Team
  • Contact
  • Investor Portal
  • Our Eco-design Approach

NEWS

Our Latest News

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

ARCHIMED acquires Direct Healthcare Group (DHG) from NorthEdge

 January

 25, 

2023

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

 October

 7, 

2022

ARCHIMED Impact Report 2021 – Investing for Better Healthcare: a Global Challenge

 October

 4, 

2022

ARCHIMED acquires Nasdaq-listed Natus Medical Incorporated in $1.1 billion take-private deal

 July

 21, 

2022

ARCHIMED invests in Title21 Health Solutions, a leading US-based healthcare software provider

 July

 12, 

2022

ARCHIMED invests in Corealis Pharma, a North American CDMO, through MED III

 May

 24, 

2022

1 2 3 … 12 >
  • ARCHIMED © 2022
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
    Go top

    Back to top